Introduction ▼
During malignant transformation, invasiveness is determined by complex functions of tumor cells of distinct histological types. A three-step model of invasion has been applied to a variety of malignant cell types. Tumor cells at the invasive site 1) detach from the growing primary tumor mass; 2) adhere to the extracellular matrix (ECM) via specifi c receptors; and 3) locally degrade the ECM components, forming a pathway for neoplastic cells to migrate into the surrounding tissue [51] . Malignant gliomas are the most common primary brain tumors. They are associated with the shortest survival time because of their infi ltrative invasion of the normal brain, which makes complete removal of these tumors practically impossible. Invasive primary brain tumors are almost invariably fatal, recurring close to the resection margin in almost all cases. Primary brain tumors have a strong tendency to invade Tumor cell invasion into the surrounding brain tissue is mainly responsible for the failure of radical surgical resection, with tumor recurrence in the form of microdisseminated disease. Extracellular matrix (ECM)-related molecules and their receptors predominantly participate in the invasion process, including cell adhesion to the surrounding microenvironment and cell migration. The extent of infi ltration of the healthy brain by malignant tumors strongly depends on the tumor cell type. Malignant gliomas show much more intensive peritumoral invasion than do metastatic tumors. In this study, the mRNA expression of 30 invasion-related molecules (twenty-one ECM components, two related receptors, and seven ECM-related enzymes) was investigated by quantitative reverse transcriptase-polymerase chain reaction. Fresh frozen human tissue samples from glioblastoma (GBM), intracerebral lung adenocarcinoma metastasis, and normal brain were evaluated. Signifi cant diff erences were established for 24 of the 30 molecules. To confi rm our results at the protein level, immunohistochemical analysis of seven molecules was performed (agrin, neurocan, syndecan, versican, matrix metalloproteinase 2 [MMP-2], MMP-9, and hyaluronan). Determining the diff erences in the levels of invasion-related molecules for tumors of diff erent origins can help to identify the exact molecular mechanisms that facilitate peritumoral infi ltration by glioblastoma cells. These results should allow the selection of target molecules for potential chemotherapeutic agents directed against highly invasive malignant gliomas.
synthases also strongly infl uence invasiveness because of their capacity to alter the actual levels of the ECM molecules or to degrade the pericellular network [4] . To understand the evident diff erences between glioblastoma (GBM) and intracerebral metastasis, we compared the mRNA expression of 30 invasion-related molecules in GBM and intracerebral bronchial adenocarcinoma metastases. To analyze their relationship to the environment, the same expression patterns were also determined in normal brain tissue. For morphological information and to check whether or not diff erences in mRNA expression appear on a post-translational level, immunohistochemical analyses were performed for seven molecules (agrin, neurocan, syndecan, versican, matrix metalloproteinase 2 [MMP-2], MMP-9, and HA).
Material and Methods

▼ Tissue samples
Thirty tissue samples were collected during neurosurgical operations. The samples were frozen promptly after removal on the surface of liquid nitrogen and stored at -80 ° C until processing. Each sample was collected from a diff erent patient. Eleven pieces of infi ltrated margins of GBMs, ten pieces of intracerebral lung adenocarcinoma metastases, and nine normal brain tissue samples taken from epilepsy surgery were carefully selected by an experienced neuropathologist for further investigation. Sections for histological analysis and immunohistochemistry were cut from the same samples used for the mRNA assays. The fresh frozen tissue samples were provided by the Neurosurgical Tissue and Tumor Bank of the Neurosurgical Department of our university. All procedures were approved by the Ethical Committee and every patient signed an informed consent form.
RNA analysis
The mRNA expression of 30 ECM-related molecules was determined by real-time quantitative reverse transcriptase-polymerase chain reaction (RT -PCR): 21 PGs, three diff erent MMPs, three hyaluronan synthases (HASs), chondroitinase ABC, and the two cell membrane receptors CD44 and CD168. Tumor markers (glial fi brillary acidic protein [GFAP], carcinoembryonic antigen [CEA] , and cytokeratins 18 and 19) and the proliferation marker Ki-67, were also tested. Fresh-frozen tissue samples were fi rst pulverized with a manual CryoPress device (Microtec Co., Japan) precooled in liquid N 2 . The powdered still-frozen tissue was then scraped into the appropriate volume of TriReagent (Invitrogen, USA) and homogenized instantly with a rotor-stator homogenizer. Total RNA was isolated from the TriReagent lysates according to the manufacturer ' s instructions. RNA purity and quantity were assessed on a NanoDrop ® ND-1000 spectrophotometer (NanoDrop Technologies, USA) and then stored at -80 ° C. RNA quality was checked on 1.2 % agarose gel stained with ethidium bromide. Total RNA was converted to single-stranded cDNA with the High-Capacity cDNA Archive Kit with RNasin (Applied Biosystems, USA) using 600 ng of total RNA per sample in one reverse transcription reaction. The cDNA transcribed from 100 ng of total RNA was loaded per port of the microfl uidic card. TaqMan Low Density Array (TLDA) experiments were performed using the Applied Biosystems 7 900 HT real-time PCR system with the Micro Fluidic Card upgrade (Applied Biosystems, USA ) relative to those of the normal samples, this allowed inspection of individual mRNA expression (X) diff erences within sample categories. To identify genes with signifi cantly diff erent expression levels between diff erent sample groups Mann-Whitney U -test was performed. Signifi cance was established at p < 0.05.
Immunohistochemistry
After evaluating the results of the mRNA determination seven molecules were selected and investigated at the protein level with immunohistochemistry: agrin, neurocan, syndecan, versican, MMP-2, − 9, and hyaluronan. Frozen and stored ( − 80 ° C) samples were fi xed in Saint Marie ' s fi xative [37, 44] for 24 h at 4 ° C. After fi xation and dehydration, the tissue samples were embedded in wax, and 5 μ m sections were cut. The sections were stained with hematoxylin-eosin and immunohistochemical reactions were carried out according to the following protocol. Slides were preincubated in ready-to-use (2.5 % ) normal horse serum (Vector, Burlingame, CA, USA) for 30 min at 37 ° C to prevent nonspecifi c binding of the primary antibodies. The sections were then incubated overnight at 4 ° C with the appropriately diluted antibodies. To promote the morphological evaluation a supplementary section for immunohistochemical and routine hemalaun staining was also performed. The immunohistochemical and HA reactions were visualized with the avidin-biotin-peroxidase complex, and the peroxidase was detected with a solution containing the H 2 O 2 substrate and the diaminobenzidine (DAB) chromogen (ImmPress Reagent Kit, Vector; Peroxidase Substrate DAB Kit, Vector). Finally, the nuclei were labeled with hemalaun staining, and the sections were mounted in DePeX (BDH Laboratory Supplies, Poole, UK). To control for the specifi city of the immunohistochemical reactions, sections were treated with the same protocol, excluding the primary antibodies, which were replaced with nonimmune IgG (Sigma, St Louis, MO, USA) solution at the optimal dilution for the diff erent primary antibodies. HA was detected with a biotinylated HA-binding complex probe (bHABC), which contains the hyaluronan-binding G1 domain of the cartilage PG, aggrecan, and link protein, which have high affi nity and specificity for HA [42] . The bHABC probe was kindly provided by R. Tammi and M. Tammi (Institute for Biomedicine, Department of Anatomy, University of Kuopio, Kuopio, Finland). The probe was used at a concentration of 5 μ g / mL, and the reaction was performed as described previously [9] . The reactions were evaluated by three diff erent investigators experienced in histology on a score of 1 -5 in three diff erent locations: intracellular, cell-membrane, and extracellular regions, which were evaluated separately for morphological information. The scores of the regions were then summed for general comparison.
Results
▼
Thirty tissue samples were investigated from three diff erent homogeneous groups of tissues: eleven GBM samples originating from the infi ltrated margins of the tumor, ten intracerebral lung adenocarcinoma metastases, and nine normal brain tissues. The results of the statistical analysis for diff erences in mRNA expression levels of 34 molecules between the investigated sample groups are summarized in • ▶ Table 1 .
mRNA expression level
The mRNA expression of the tumor markers and the Ki67 proliferation marker confi rmed the histological diagnosis. The mRNA expression of the investigated molecules is illustrated in • ▶ Fig. 1 .
GBM versus normal brain
The expression of mRNAs for agrin, fi bronectin, laminin α -4, β -1 and β -2, perlecan, syndecan-1, tenascin-C, CD44, CD168, HAS-2, MMP-2 and -9 was signifi cantly elevated in GBM relative to that in the normal brain, whereas the mRNA expression of syndecan-4, tenascin-R and HAS-1 was statistically lower in the GBM. The mRNA levels of aggrecan, brevican, laminin α -1, -2, laminin β -1, laminin γ -1, matrilin-1 and -2, neurocan, neuroglycan, syndecan-2, versican, chondroitinases, HAS-3, and MMP-8 did not differ signifi cantly between normal brain and GBM.
Intracerebral lung adenocarcinoma metastases versus normal brain
Signifi cantly reduced mRNA expression of brevican, laminin α -1, matrilin-2, neurocan, neuroglycan-C, syndecan-2, tenascin-R, and HAS-1 was detected in lung adenocarcinoma metastases compared with that in normal brain. Conversely, the expression of agrin, fi bronectin, laminin β -1, β -2 and γ -1, perlecan, syndecan-1 and -4, CD168 and MMP-9 mRNAs was statistically elevated in the metastatic tumor relative to that in normal brain. There was no apparent diff erence in the expression of aggrecan, laminin α -2, -4, matrilin-1, tenascin-C, versican, CD44, chon- Table 1 Signifi cant diff erences (bold) in the mRNA expression levels of 30 invasion-related molecules and fi ve tumor markers in glioblastoma (GBM), intracere bral lung adenocarcinoma metastasis (Met), and normal brain tissues (Norm).
Norm -Met
Norm -GBM GBM -Met 
GBM versus intracerebral lung adenocarcinoma metastases
In a comparison of the anaplastic tumors of diff erent origins, the mRNA expression of brevican, matrilin-2, neurocan, neuroglycan-C, tenascin-C and R, CD44, HAS-2 and MMP-2 was significantly higher in GBM compared to lung adenocarcinoma metastases. The transcripts of syndecan-1 and syndecan-4 were signifi cantly elevated in the intracerebral adenocarcinoma. We detected no statistically signifi cant diff erences in agrin, aggrecan, fi bronectin, laminin α -1,-2 or -4, laminin β -1, -2, laminin γ -1, matrilin-1, perlecan, syndecan-2, versican, CD168, chondroitinase, HAS-1 and -3, or MMP-8, and -9 transcripts.
Immunohistochemistry
The immunohistochemical and HA histochemical reactions are summarized in • ▶ Fig. 2 . According to the morphological evaluation, immunoreactivity for agrin, neurocan, syndecan, and versican was most intense mainly on the cell membrane and in the extracellular space, whereas the MMPs showed strong immunoreactivity on the cell membrane and intracellularly. Most intense immunostaining of agrin, syndecan and MMP-9 was observed in the lung adenocarcinoma metastases, while MMP-2, neurocan and hyaluronan showed the highest values in GBM samples. The a g g re c a n a g ri n b re v ic a n fi b ro n e c ti n la m in in a lf a -1 la m in in a lf a -2 la m in in a lf a -4 la m in in b e ta -1 la m in in b e ta -2 la m in in g a m m a -1 m a tr il in -1 m a tr il in -2 n e u ro c a n n e u ro g ly c a n -C p e rl e c a n s y n d e c a n -1 s y n d e c a n -2 s y n d e c a n -4 te n a s c in -C te n a s c in -R v e rs ic a n C D 4 4 C D 1 6 8 c h o n d ro it in a s e s (A C , A B C ) h y a lu ro n a n s y n th a s e -1 h y a lu ro n a n s y n th a s e -2 h y a lu ro n a n s y n th a s e -3 M M P -2 M M P -8 M M P -9 c y to k e ra ti n 1 8 c y to k e ra ti n 1 9 G F A P K i6 7 a g g re c a n a g ri n b re v ic a n fi b ro n e c ti n la m in in a lf a -1 la m in in a lf a -2 la m in in a lf a -4 la m in in b e ta -1 la m in in b e ta -2 la m in in g a m m a -1 m a tr il in -1 m a tr il in -2 n e u ro c a n n e u ro g ly c a n -C p e rl e c a n s y n d e c a n -1 s y n d e c a n -2 s y n d e c a n -4 te n a s c in -C te n a s c in -R v e rs ic a n C D 4 4 C D 1 6 8 c h o n d ro it in a s e s (A C , A B C ) h y a lu ro n a n s y n th a s e -1 h y a lu ro n a n s y n th a s e -2 h y a lu ro n a n s y n th a s e -3
c y to k e ra ti n 1 8 c y to k e ra ti n 1 9 G F A P K i6 7 a g g re c a n a g ri n b re v ic a n fi b ro n e c ti n la m in in a lf a -1 la m in in a lf a -2 la m in in a lf a -4 la m in in b e ta -1 la m in in b e ta -2 la m in in g a m m a -1 m a tr il in -1 m a tr il in -2 n e u ro c a n n e u ro g ly c a n -C p e rl e c a n s y n d e c a n -1 s y n d e c a n -2 s y n d e c a n -4 te n a s c in -C te n a s c in -R v e rs ic a n C D 4 4 C D 1 6 8 c h o n d ro it in a s e s (A C , A B C ) h y a lu ro n a n s y n th a s e -1 h y a lu ro n a n s y n th a s e -2 h y a lu ro n a n s y n th a s e -3 M M P -2 M M P -8 M M P -9 c y to k e ra ti n 1 8 c y to k e ra ti n 1 9 G F A P K i6 7 staining intensity of tumor markers and Ki-67 was in accordance with the histology.
Discussion ▼
Gliomas are the most common primary intracranial tumors. The incidence of brain metastasis is about double the number of primary brain tumors, and more than half of them originate from lung cancer [11] . Both tumor types are anaplastic, dediff erentiated neoplasms, but their biological behaviour and thus their therapeutic management diff ers considerably. The unambiguous ability of high grade gliomas to invade normal neural tissue makes them diffi cult to control and makes complete surgical resection almost impossible. This also explains the extremely high mortality associated with anaplastic gliomas. In contrast, the invasiveness of intracerebral metastases of anaplastic tumors is much more moderate, and radical surgical removal can be achieved in most cases. The extracellular matrix plays a pivotal role in the tumorous infi ltration of the surrounding tissue. The presence and functions of hyaluronic acid, PGs, synthetic and lytic enzymes, and specifi c adhesion receptors have already been intensively investigated to clarify the molecular mechanisms of invasion, and a positive correlation has been established many times [4, 17, 18, 22, 31, 39] . To identify the molecules that are probably responsible for the distinct invasiveness of high-grade gliomas and metastatic tumors, the mRNA expression of 30 invasion-related molecules was measured in fresh-frozen neurosurgical tissue samples of GBM, intracerebral lung adenocarcinoma metastases, and normal brain tissue. Based on data from the literature, 21 ECM components, seven proteases, the membrane receptor for hyaluronan (CD44), and CD168 were selected for quantitative RT -PCR. To verify the results of mRNA analysis, immunohistochemical analysis of seven molecules (agrin, neurocan, syndecan, versican, MMP-2, MMP-9, and hyaluronan) was performed. The mRNA expression patterns of the analyzed chosen molecules are illustrated in • ▶ Fig. 1 .
Previous studies have described a positive correlation between the invasion potential of gliomas and the expression of brevican [10, 46] , fi bronectin [25, 43] , laminin [13, 25] , syndecan [48] , tenascin-C [16, 52] , versican [32] , MMP-9 [3, 40, 53] , hyaluronan [7] , and CD44 [30, 35, 49] . We also detected signifi cant diff erences in the mRNA profi les of normal brain and GBM for fi bronectin, laminin β -1, perlecan, syndecan-1, -4, tenascin-C, -R, CD44, CD168, HAS-1, -2, and MMP-2 and -9. There are no relevant data in the literature relating astrocytomas to changes in the levels of aggrecan, matrilin, perlecan, neuroglycan-C, neurocan, CD168, or chondroitinase. In this study the mRNA expression of perlecan and CD168 was signifi cantly higher in gliobastomas compared to normal brain, while there were no evident diff erences between the others. ECM components and invasion-related molecules have also been studied in some cases of non-small-cell lung carcinoma. In bronchial adenocarcinomas, elevated levels of hyaluronan [33] , fi bronectin [15, 19] , laminin [28, 41] , versican [34] , MMP-9 [3] , MMP-2 [8] , and CD44 [21] have been reported, whereas increased levels of perlecan, tenascin-C, and syndecan do not correlate well with tumor progression [14, 27, 38] . There are no data supporting a defi nite correlation between agrin, brevican, matrilin, neuroglycan-C, neurocan, CD168, chondroitinase, or HAS and the tumor behavior of lung adenocarcinoma. Comparing the intracerebral lung adenocarcinoma metastases with normal brain, we detected a signifi cant diff erence in the mRNA expression of 18 molecules out of the 30 tested ( • ▶ Table 1 ). There are some molecules that are specifi c for the tissue of origin (e. g. brevican, neurocan, neuroglycan-C in the brain samples), while others probably play an important role in peritumoral invasion (fi bronectin, syndecan-1, -4, CD168 and MMP-9). But the explanation for the high expression of agrin, laminin β -1, β -2, γ-1 and perlecan in intracerebral lung adenocarcinoma metastasis needs further investigation. The mRNA expression of 11 molecules diff ered signifi cantly between GBM and lung adenocarcinoma metastases ( • ▶ Table 1 ).
Since brevican, matrilin-2, neurocan, neuroglycan-C and tenascin-R had a higher mRNA expression both in normal brain and in GBM compared to the metastatic tumors, these molecules can be interpreted as specifi c molecules for glial tissues. On the other hand, the mRNA expression of tenascin-C, CD44, HAS-1 and MMP-2 was elevated only in the GBM compared to the metastatic tissue. Based on these observations the high level of the former molecules might help to understand the role of ECM in GBM in avoiding antitumoral reactions of the surrounding brain tissue. Furthermore, the role of the latter molecules in the diff erence in invasion eff ectiveness of GBM can be also hypothesized. v e r s i c a n a g r i n s y n d e c a n
n e u r o c a n h y a l u r o n a n Fig. 2 Immunohistochemical (IHC) evaluation of four proteoglycans, two matrix metalloproteinases, and hyaluronic acid in glioblastoma, intracerebral lung adenocarcinoma metastasis (Met), and normal brain (Norm). The reactions were evaluated by three diff erent investigators experienced in histology on a score of 1 -5 in three diff erent regions. The scores of the regions were then summed for general comparison.
Lung adenocarcinoma metastases had high expression of syndecan-1 and -4, but this proved to be insuffi cient for invading the peritumoral brain. BEHAB (brain enriched hyaluronan binding) / brevican, a brainspecifi c chondroitin sulfate PG, shows dramatic upregulation in gliomas and it is also upregulated during periods of increased glial cell motility during development and following brain injury [29] . Viapiano et al. established that brevican expression in gliomas have a restricted membrane localization, and its presence in high-grade gliomas suggests that it may play a signifi cant role in glioma progression, making it an important new potential therapeutic target [45] . We detected no signifi cant diff erence in mRNA expression of brevican between the normal brain and GBM, thus our data does not support the role of brevican in GBM progression.
Although the mRNA expression of fi bronectin was found to be signifi cantly higher in GBM than in normal brain, it was also defi nitely high in lung adenoracinoma metastases as well, so that the role of fi bronectin in the diff erent invasion activity of the two diff erent tumor types is not supported by our results. Neurocan, a chondroitin-sulphate PG, is involved in the promotion of neurite outgrowth through interaction with heparan-sulphate PGs [1] . We found signifi cantly lower mRNA expression of neurocan in the lung adenocarcinoma metastases than in GBM, but the highest value was detected in the normal brain, so the role of neurocan in the invasion process of GBM is not clear yet. Based on our results it could be hypothesized that neurocan plays a predominant part in cell diff erentiation and not in cell proliferation or migration. The reason might be that neurocan promotes normal neurite outgrowth and not tumoral membrane processes. Further investigations are needed for a more precise explanation. Neuroglycan-C, another chondroitin-sulphate PG, is a ligand of epidermal growth factor receptor (EGFR) Erb-B3 and thus plays an active role in tumor growth [2, 20] . The mRNA expression of neuroglycan-C was found to be signifi cantly lower in lung adenocarcinoma metastases than in the other two groups, but the highest value was detected in normal brain, which does not support its putative role in glioma invasion. Syndecans were previously found to play a part in glioma invasion [48] . We found the highest mRNA expression of snydecan-1 and 4 in lung adenocarcinoma metastases and syndecan-2 in normal brain. Based on these data we can not determine their specifi c role in the extremely high infi ltrative activity of GBM. Tenascin-C is a glycoprotein of the ECM that was reported to be positively correlated to glioma invasion [9, 27] and have a negative correlation with tumor progression of bronchial adenocarcinomas [14, 27, 38] . Since we also detected a higher mRNS expression of tenascin-C in GBM than in lung adenocarcinoma metastases, and it was low again in normal brain, a specifi c role of tenascin-C in glioma invasion can be strongly hypothesized. Versican is one of the most common ECM components in the brain and plays a role in neurite outgrowth, cell attachment and EGFR-mediated signal pathways [50] . Its elevated expression in gliomas has been described previously [32] . We detected elevated mRNA expression of versican in GBM compared to lung adenocarcinoma metastases and normal brain, but the diff erence was not confi rmed stastically. The positive correlation between CD44 and glioma grading and the functional connection between HA and CD44 has been reported many times [30, 35, 49] , and a similar association is also known with regard to lung adenocarcinomas [22] . In our study we detected signifi cantly elevated CD44 mRNS expression in GBM compared to lung adenocarcinoma metastases with a low CD44 mRNS expression in normal brain, indicating that CD44 may play an important role in the invasion process of malignant gliomas. HAS-2 also showed increased mRNA expression in GBM compared to lung adenocarcinoma metastases or normal brain, and immunostaining of HA was most intensive in GBM. These observations emphasize the common function of CD44 and HAS-2 in tumor infi ltration of the surrounding brain. The role of metalloproteinases in tumor invasion and their representative subtypes in gliomas and bronchial adenocarcinomas has already been described [3, 8, 40, 53] . Our observation that mRNA expression of MMP-2 is signifi cantly higher in GBM than in lung adenocarcinoma metastases and normal brain defi nitely underlines its role in the diff erent invasiveness of the two diff erent tumor types. The immunostaining profi le of MMP-2 was in accordance with the results of the investigations into mRNA expression.
Comparison of mRNA expression and immunohistochemical fi ndings
To investigate the appearance of the diff erent mRNA expressions on a post-translational level and obtain morphological information, immunohistochemical analyses were performed for seven molecules (agrin, neurocan, syndecan, versican, matrix metalloproteinase 2 [MMP-2], MMP-9, and HA). The changes in the intensity of immunostaining between the three tissue sample groups correlated well with the changes in mRNA expression for versican, agrin, syndecan and MMP-2 ( • ▶ Fig. 2 ). In immunohistochemical analysis, agrin, syndecan and MMP-9 were predominant in bronchial adenocarcinoma, whereas MMP-2, neurocan and hyaluronan showed the greatest intensity of immunostaining in GBM. Interestingly, the highest staining intensity and mRNA expression of agrin was detected in the metastasis group. Agrin is an important component of the blood-brain barrier [36, 47] , but its presence and role in intracerebral lung adenocarcinoma metastases has not yet been clarifi ed. MMP-9 showed the strongest immunostaining intensity in lung adenocarcinoma metastases, but its highest mRNA expression was measured in GBM. The highest mRNA expression of neurocan was detected in normal brain, but immunohistochemistry showed a slightly increased staining intensity in the tumors. These fi ndings are probably attributable to post-transcriptional events, but further investigation is required. HA was found to be mostly present in GBM. Since the mRNA expression of its receptor CD44 was also highest in GBM, their common role in the invasion process can be affi rmed.
Conclusions ▼
By comparing the mRNA expression of 30 invasion-related molecules in GBM, normal brain, and intracerebral lung adenocarcinoma metastasis, some molecules that probably play a role in the extremely high invasive activity of GBM could be identifi ed. Based on these results, tenascin-C, CD44, and MMP-2 seem to be predominantly involved in peritumoral infi ltration by GBM, but a clear role of fi bronectin and syndecans in the diff erent infi ltrative activity of these tumors could not be confi rmed. Adding new data to previous observations, the levels of brevican, neurocan, neuroglycan-C and matrilin-2 were also shown to diff er signifi cantly between lung adenocarcinoma metastasis and GBM. Because ECM components, proteases, and their receptors have been shown to play an important role in tumor cell migration and invasion, each identifi ed component could be investigated further as a potential target for anticancer therapy.
